Insider Stock Trading History of Ellis P Ron


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ellis P Ron since year 2005. The trader's CIK number is 1509418. At the time of this reporting, Ellis P Ron is the President and CEO of Endocyte Inc . (stock ticker symbol ECYT). See this page for all insider trading activities at Endocyte Inc .


Stock purchases, sales, and option exercises reported by insider Ellis P Ron since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-02-06 ECYT Endocyte Inc Option Ex 52,356 5.21 272,774
2014-11-05 ECYT Endocyte Inc Option Ex 19,060 1.91 36,404
2014-03-10 ECYT Endocyte Inc Option Ex 80,000 1.91 152,800
2013-12-02 ECYT Endocyte Inc Sale 3,000 12.00 36,000
2013-12-04 ECYT Endocyte Inc Option Ex 3,000 1.91 5,730
2013-11-06 ECYT Endocyte Inc Sale 3,000 12.00 36,000
2013-11-07 ECYT Endocyte Inc Option Ex 3,000 1.91 5,730
2013-10-02 ECYT Endocyte Inc Option Ex 3,000 1.91 5,730
2013-10-01 ECYT Endocyte Inc Sale 3,000 13.30 39,900
2013-09-04 ECYT Endocyte Inc Option Ex 3,000 1.91 5,730
2013-09-03 ECYT Endocyte Inc Sale 3,000 14.54 43,620
2013-08-02 ECYT Endocyte Inc Option Ex 3,000 1.91 5,730
2013-08-01 ECYT Endocyte Inc Sale 3,000 18.12 54,360
2013-07-16 ECYT Endocyte Inc Option Ex 3,000 1.91 5,730
2013-07-15 ECYT Endocyte Inc Sale 3,000 17.01 51,030
2013-05-01 ECYT Endocyte Inc Sale 500 13.88 6,940
2013-04-01 ECYT Endocyte Inc Sale 500 12.54 6,270
2013-03-27 ECYT Endocyte Inc Sale 1,500 12.00 18,000
2012-12-31 ECYT Endocyte Inc Sale 6,000 8.75 52,500
2011-12-16 ECYT Endocyte Inc Option Ex 21,998 1.36 30,027
2011-08-05 ECYT Endocyte Inc Option Ex 14 .19 2
2011-02-04 ECYT Endocyte Inc Buy 2,500 6.00 15,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ellis P Ron (President and CEO of Endocyte Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.